ShareCompartir
Volume 7, Number 1—February 2001
Synopsis
Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates
Jørgen Engberg*
, Frank M. Aarestrup†, Diane E. Taylor‡, Peter Gerner-Smidt*, and Irving Nachamkin§
, Frank M. Aarestrup†, Diane E. Taylor‡, Peter Gerner-Smidt*, and Irving Nachamkin§
Figure 1
Figure 1. Macrolide and fluoroquinolone resistance mechanisms reported in Campylobacter species. For macrolide resistance, mutations are at either position shown (Escherichia coli coordinates) in up to all three copies of ribosomal RNA (14,15, and CA Trieber & DE Taylor, unpub. data). Fluoroquinolone resistance depends on a mutation in the quinolone resistance determining region of DNA gyrase A (GyrA). For typical MICs see text and references 16-18. The strains with highest resistance levels had mutations in both GyrA and topoisomerase IV ParC.
- Page created: March 16, 2011
- Page last updated: March 16, 2011
- Page last reviewed: March 16, 2011
- Centers for Disease Control and Prevention,
-
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)